Bain Capital Life Sciences Fund IV

Overview

Bain Capital Life Sciences Fund IV is the fourth vehicle in Bain Capital's dedicated life sciences/biotech investment strategy, closing in September 2024 at approximately $3 billion in total commitments (~$2.5B from outside LPs plus GP/affiliated capital), investing across the biotech and life sciences sector amid a wave of startup buyouts. Confirmed LP: CalPERS (California Public Employees' Retirement System), one of the fund's five limited partners.

Key Facts

Fund type

Growth/VC

Vintage year

2024

Strategy

Life Sciences — pharmaceuticals, biotech, medical devices, diagnostics

Managed by

Bain Capital

Fund size

USD 3.0B